vs
Side-by-side financial comparison of P3 Health Partners Inc. (PIII) and Revolve Group, Inc. (RVLV). Click either name above to swap in a different company.
P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $324.4M, roughly 1.2× Revolve Group, Inc.). Revolve Group, Inc. runs the higher net margin — 5.7% vs -19.6%, a 25.3% gap on every dollar of revenue. On growth, Revolve Group, Inc. posted the faster year-over-year revenue change (10.4% vs 3.8%). Over the past eight quarters, Revolve Group, Inc.'s revenue compounded faster (9.5% CAGR vs -0.5%).
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
Revolve Theatre Company is a Henley-on-Thames based theatre company specialising in political and Shakespearean plays. The company is owned by Oliver Dench, Joe Morris and Tom Smith.
PIII vs RVLV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $384.8M | $324.4M |
| Net Profit | $-75.5M | $18.6M |
| Gross Margin | — | 53.3% |
| Operating Margin | -40.0% | 6.3% |
| Net Margin | -19.6% | 5.7% |
| Revenue YoY | 3.8% | 10.4% |
| Net Profit YoY | -28.8% | 50.4% |
| EPS (diluted) | $-23.08 | $0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $384.8M | $324.4M | ||
| Q3 25 | $345.3M | $295.6M | ||
| Q2 25 | $355.8M | $309.0M | ||
| Q1 25 | $373.2M | $296.7M | ||
| Q4 24 | $370.7M | $293.7M | ||
| Q3 24 | $362.1M | $283.1M | ||
| Q2 24 | $379.2M | $282.5M | ||
| Q1 24 | $388.5M | $270.6M |
| Q4 25 | $-75.5M | $18.6M | ||
| Q3 25 | $-31.6M | $21.2M | ||
| Q2 25 | $-20.4M | $10.2M | ||
| Q1 25 | $-20.5M | $11.8M | ||
| Q4 24 | $-58.6M | $12.3M | ||
| Q3 24 | $-46.5M | $11.0M | ||
| Q2 24 | $-12.0M | $15.4M | ||
| Q1 24 | $-18.7M | $10.9M |
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 54.0% | ||
| Q1 24 | — | 52.3% |
| Q4 25 | -40.0% | 6.3% | ||
| Q3 25 | -12.8% | 7.1% | ||
| Q2 25 | -9.6% | 5.8% | ||
| Q1 25 | -10.2% | 5.0% | ||
| Q4 24 | -37.4% | 3.9% | ||
| Q3 24 | -29.5% | 5.0% | ||
| Q2 24 | -8.3% | 5.8% | ||
| Q1 24 | -11.3% | 3.4% |
| Q4 25 | -19.6% | 5.7% | ||
| Q3 25 | -9.1% | 7.2% | ||
| Q2 25 | -5.7% | 3.3% | ||
| Q1 25 | -5.5% | 4.0% | ||
| Q4 24 | -15.8% | 4.2% | ||
| Q3 24 | -12.8% | 3.9% | ||
| Q2 24 | -3.2% | 5.4% | ||
| Q1 24 | -4.8% | 4.0% |
| Q4 25 | $-23.08 | $0.27 | ||
| Q3 25 | $-9.67 | $0.29 | ||
| Q2 25 | $-6.23 | $0.14 | ||
| Q1 25 | $-6.28 | $0.16 | ||
| Q4 24 | $-23.13 | $0.18 | ||
| Q3 24 | $-15.70 | $0.15 | ||
| Q2 24 | $-7.37 | $0.21 | ||
| Q1 24 | $-7.86 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.0M | $292.3M |
| Total DebtLower is stronger | $228.4M | — |
| Stockholders' EquityBook value | $-155.2M | $512.5M |
| Total Assets | $656.6M | $765.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.0M | $292.3M | ||
| Q3 25 | $37.7M | $315.4M | ||
| Q2 25 | $38.6M | $310.7M | ||
| Q1 25 | $40.1M | $300.8M | ||
| Q4 24 | $38.8M | $256.6M | ||
| Q3 24 | $63.0M | $252.8M | ||
| Q2 24 | $73.1M | $244.7M | ||
| Q1 24 | $27.3M | $273.4M |
| Q4 25 | $228.4M | — | ||
| Q3 25 | $252.8M | — | ||
| Q2 25 | $182.0M | — | ||
| Q1 25 | $171.1M | — | ||
| Q4 24 | $108.9M | — | ||
| Q3 24 | $133.2M | — | ||
| Q2 24 | $133.1M | — | ||
| Q1 24 | $118.1M | — |
| Q4 25 | $-155.2M | $512.5M | ||
| Q3 25 | $-18.7M | $490.2M | ||
| Q2 25 | $44.5M | $468.6M | ||
| Q1 25 | $63.3M | $453.4M | ||
| Q4 24 | $75.9M | $437.8M | ||
| Q3 24 | $120.5M | $420.8M | ||
| Q2 24 | $166.8M | $405.8M | ||
| Q1 24 | $146.6M | $389.9M |
| Q4 25 | $656.6M | $765.0M | ||
| Q3 25 | $683.6M | $751.3M | ||
| Q2 25 | $731.6M | $722.9M | ||
| Q1 25 | $783.9M | $713.9M | ||
| Q4 24 | $783.4M | $665.5M | ||
| Q3 24 | $833.3M | $670.9M | ||
| Q2 24 | $892.8M | $657.8M | ||
| Q1 24 | $855.9M | $650.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.09× | — | ||
| Q1 25 | 2.71× | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.80× | — | ||
| Q1 24 | 0.81× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.7M | $-10.2M |
| Free Cash FlowOCF − Capex | — | $-13.3M |
| FCF MarginFCF / Revenue | — | -4.1% |
| Capex IntensityCapex / Revenue | — | 1.0% |
| Cash ConversionOCF / Net Profit | — | -0.55× |
| TTM Free Cash FlowTrailing 4 quarters | — | $48.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.7M | $-10.2M | ||
| Q3 25 | $-15.4M | $11.8M | ||
| Q2 25 | $-16.6M | $12.6M | ||
| Q1 25 | $-33.5M | $45.1M | ||
| Q4 24 | $-57.2M | $3.9M | ||
| Q3 24 | $-22.6M | $9.1M | ||
| Q2 24 | $-10.2M | $-24.7M | ||
| Q1 24 | $-20.0M | $38.4M |
| Q4 25 | — | $-13.3M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $8.0M | ||
| Q2 24 | — | $-25.7M | ||
| Q1 24 | — | $36.7M |
| Q4 25 | — | -4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | -9.1% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | 0.0% | 0.6% | ||
| Q3 24 | 0.0% | 0.4% | ||
| Q2 24 | 0.0% | 0.4% | ||
| Q1 24 | 0.0% | 0.6% |
| Q4 25 | — | -0.55× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | — | 3.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
